STK11-C19ORF26 Fusion FISH Probe
The STK11-C19ORF26 Fusion FISH Probe is used to confirm a fusion of the STK11 and C19ORF26 genes. The fusion of the STK11 and C19ORF26 genes has been associated with Bladder Urothelial Carcinoma. These probes are FISH confirmed on normal peripheral blood in both interphase nuclei and metaphase spreads before shipment. Typical turnaround time for this product is 7-14 days after purchase.
** This product is for in vitro and research use only. This product is not intended for diagnostic use. Please note that both genes fall on the same chromosome and inter-chromosomal detection may be difficult to detect depending on the genes proximity to one another. Please consult our support staff before ordering this product to ensure that the probe can be designed to meet your specific needs.
| SKU | Test Kits | Buffer | Dye Color | Order Now |
|---|---|---|---|---|
| STK11-C19ORF26-20-ORGR (Standard Design) | 20 (40 μL) | 200 μL |
|
|
| STK11-C19ORF26-20-RERE | 20 (40 μL) | 200 μL |
|
|
| STK11-C19ORF26-20-REOR | 20 (40 μL) | 200 μL |
|
|
| STK11-C19ORF26-20-REGO | 20 (40 μL) | 200 μL |
|
|
| STK11-C19ORF26-20-REGR | 20 (40 μL) | 200 μL |
|
|
| STK11-C19ORF26-20-REAQ | 20 (40 μL) | 200 μL |
|
|
| STK11-C19ORF26-20-ORRE | 20 (40 μL) | 200 μL |
|
|
| STK11-C19ORF26-20-OROR | 20 (40 μL) | 200 μL |
|
|
| STK11-C19ORF26-20-ORGO | 20 (40 μL) | 200 μL |
|
|
| STK11-C19ORF26-20-ORAQ | 20 (40 μL) | 200 μL |
|
|
| STK11-C19ORF26-20-GORE | 20 (40 μL) | 200 μL |
|
|
| STK11-C19ORF26-20-GOOR | 20 (40 μL) | 200 μL |
|
|
| STK11-C19ORF26-20-GOGO | 20 (40 μL) | 200 μL |
|
|
| STK11-C19ORF26-20-GOGR | 20 (40 μL) | 200 μL |
|
|
| STK11-C19ORF26-20-GOAQ | 20 (40 μL) | 200 μL |
|
|
| STK11-C19ORF26-20-GRRE | 20 (40 μL) | 200 μL |
|
|
| STK11-C19ORF26-20-GROR | 20 (40 μL) | 200 μL |
|
|
| STK11-C19ORF26-20-GRGO | 20 (40 μL) | 200 μL |
|
|
| STK11-C19ORF26-20-GRGR | 20 (40 μL) | 200 μL |
|
|
| STK11-C19ORF26-20-GRAQ | 20 (40 μL) | 200 μL |
|
|
| STK11-C19ORF26-20-AQRE | 20 (40 μL) | 200 μL |
|
|
| STK11-C19ORF26-20-AQOR | 20 (40 μL) | 200 μL |
|
|
| STK11-C19ORF26-20-AQGO | 20 (40 μL) | 200 μL |
|
|
| STK11-C19ORF26-20-AQGR | 20 (40 μL) | 200 μL |
|
|
| STK11-C19ORF26-20-AQAQ | 20 (40 μL) | 200 μL |
|
STK11 Gene Summary
This gene, which encodes a member of the serine/threonine kinase family, regulates cell polarity and functions as a tumor suppressor. Mutations in this gene have been associated with Peutz-Jeghers syndrome, an autosomal dominant disorder characterized by the growth of polyps in the gastrointestinal tract, pigmented macules on the skin and mouth, and other neoplasms. Alternate transcriptional splice variants of this gene have been observed but have not been thoroughly characterized. [provided by RefSeq, Jul 2008]
Gene Name: Serine/threonine Kinase 11
Chromosome: CHR19: 1205797 -1228434
Locus: 19p13.3
Gene Diseases
The STK11 C19ORF26 Fusion has been associated with the following diseases:
| Disease Name |
|---|
| Bladder Urothelial Carcinoma |
FISH Probe Protocols
| Protocol, Procedure, or Form Name | Last Modified | Download |
|---|